241 related articles for article (PubMed ID: 16491897)
21. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
[TBL] [Abstract][Full Text] [Related]
22. Reduced argatroban doses after coronary artery bypass graft surgery.
Hoffman WD; Czyz Y; McCollum DA; Hursting MJ
Ann Pharmacother; 2008 Mar; 42(3):309-16. PubMed ID: 18303137
[TBL] [Abstract][Full Text] [Related]
23. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Burger CF; Schlesinger JJ
Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
[TBL] [Abstract][Full Text] [Related]
24. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
Ansara AJ; Arif S; Warhurst RD
Ann Pharmacother; 2009 Jan; 43(1):9-18. PubMed ID: 19126826
[TBL] [Abstract][Full Text] [Related]
25. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
Hursting MJ; Soffer J
Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378
[TBL] [Abstract][Full Text] [Related]
26. Argatroban dosing in patients with heparin-induced thrombocytopenia.
Verme-Gibboney CN; Hursting MJ
Ann Pharmacother; 2003; 37(7-8):970-5. PubMed ID: 12841802
[TBL] [Abstract][Full Text] [Related]
27. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
Kondo LM; Wittkowsky AK; Wiggins BS
Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
[TBL] [Abstract][Full Text] [Related]
28. Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital.
Kodityal S; Nguyen PH; Kodityal A; Sherer J; Hursting MJ; Rice L
J Intensive Care Med; 2006; 21(2):86-92. PubMed ID: 16537750
[TBL] [Abstract][Full Text] [Related]
29. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
Hellwig TR; Peitz GJ; Gulseth MP
Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
[TBL] [Abstract][Full Text] [Related]
30. Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
Kim SC; Tran N; Schewe JC; Boehm O; Wittmann M; Graeff I; Hoeft A; Baumgarten G
J Cardiothorac Surg; 2015 Feb; 10():19. PubMed ID: 25879883
[TBL] [Abstract][Full Text] [Related]
31. Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ system failure.
Begelman SM; Baghdasarian SB; Singh IM; Militello MA; Hursting MJ; Bartholomew JR
J Intensive Care Med; 2008; 23(5):313-20. PubMed ID: 18701526
[TBL] [Abstract][Full Text] [Related]
32. Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Begelman SM; Hursting MJ; Aghababian RV; McCollum D
J Intern Med; 2005 Dec; 258(6):563-72. PubMed ID: 16313480
[TBL] [Abstract][Full Text] [Related]
33. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
Frame JN; Rice L; Bartholomew JR; Whelton A
Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
Kiser TH; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
[TBL] [Abstract][Full Text] [Related]
35. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.
Young G; Boshkov LK; Sullivan JE; Raffini LJ; Cox DS; Boyle DA; Kallender H; Tarka EA; Soffer J; Hursting MJ
Pediatr Blood Cancer; 2011 Jul; 56(7):1103-9. PubMed ID: 21488155
[TBL] [Abstract][Full Text] [Related]
36. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
Harenberg J; Jörg I; Fenyvesi T; Piazolo L
J Thromb Thrombolysis; 2005 Feb; 19(1):65-9. PubMed ID: 15976970
[TBL] [Abstract][Full Text] [Related]
37. Argatroban use in heparin-induced thrombocytopenia.
Boggio LN; Oza VM
Expert Opin Pharmacother; 2008 Aug; 9(11):1963-7. PubMed ID: 18627333
[TBL] [Abstract][Full Text] [Related]
38. Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia.
Vianello F; Furian L; Nordio M; Treleani M; Fabris F
Hematology; 2015 Jan; 20(1):48-9. PubMed ID: 24580134
[TBL] [Abstract][Full Text] [Related]
39. Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia.
Gasparovic H; Nathan NS; Fitzgerald D; Aranki SF
Ann Thorac Surg; 2004 Dec; 78(6):e89-91. PubMed ID: 15560992
[TBL] [Abstract][Full Text] [Related]
40. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
Lewis BE; Matthai WH; Cohen M; Moses JW; Hursting MJ; Leya F;
Catheter Cardiovasc Interv; 2002 Oct; 57(2):177-84. PubMed ID: 12357516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
